Autosomal Dominant Hypocalcemia (ADH)
3 clinical trials · Condition
◉ Watch Autosomal Dominant Hypocalcemia (ADH)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 (NCT05680818) | Calcilytix Therapeutics, Inc., a BridgeBio company | 2023-01-06 |
| Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1 (NCT04581629) | Calcilytix Therapeutics, Inc., a BridgeBio company | 2020-09-20 |
| A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations (NCT02204579) | Shire | 2014-07-18 |
Track Autosomal Dominant Hypocalcemia (ADH) automatically
Every clearance here is in the API, with alerts when new ones post.